Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
27 Novembre 2019 - 04:00PM
Business Wire
Pfizer Inc. invites investors and the general public to listen
to a webcast of a discussion with Mikael Dolsten, Chief Scientific
Officer and President, Worldwide Research, Development and Medical,
and Michael Vincent, Senior Vice President and Chief Scientific
Officer, Inflammation and Immunology, at the Evercore ISI 2nd
Annual HealthCONx Conference on Wednesday, December 4, 2019 at
10:15 a.m. Eastern Standard Time.
To listen to the webcast, visit our web site at
www.pfizer.com/investors. Information on accessing and
pre-registering for the webcast will be available at
www.pfizer.com/investors beginning today.
Visitors will be able to listen to an archived copy of the
webcast at www.pfizer.com/investors.
Disclosure Notice: The webcast may include
forward-looking statements about, among other things, our
anticipated future operating and financial performance, business
plans and prospects, expectations for in-line products and product
candidates, strategic reviews, capital allocation objectives,
business-development plans, benefits anticipated from the
reorganization of our commercial operations in 2019, our
acquisitions and other business development activities, including
our proposed transaction with Mylan N.V. (Mylan) to combine Upjohn
and Mylan to create a new global pharmaceutical company, our
acquisition of Array BioPharma Inc. and our transaction with GSK to
combine our respective consumer healthcare businesses into a new
consumer healthcare joint venture, our ability to successfully
capitalize on growth opportunities or prospects, manufacturing and
product supply and plans relating to share repurchases and
dividends, among other things, that are subject to substantial
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied by such statements. A
description of these risks and uncertainties can be found in
Pfizer’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2018 and in its subsequent reports on Form 10-Q,
including in the sections thereof captioned “Risk Factors” and
“Forward-Looking Information and Factors That May Affect Future
Results”, as well as in its subsequent reports on Form 8-K, all of
which are filed with the U.S. Securities and Exchange Commission
and available at www.sec.gov and www.pfizer.com.
The forward-looking statements in the webcast speak only as of
the original date of the webcast. Pfizer assumes no obligation to
update forward-looking statements contained in the webcast as the
result of new information or future events or developments.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191127005046/en/
Media Contact: Patricia Kelly (212) 733-3810
Investor Contact: Ryan Crowe (212) 733-8160
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024